
DNA vs PRME
$DNA vs $PRME head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs PRME: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·DNA is the weaker of the two on trend, below both its 50- and 200-day averages, while PRME has held above one of them.
- ·Neither kept up with the market over the past year: DNA -13.4% and PRME -6.3%, against the S&P 500 at +3.2%.
- ·PRME has support 5% below at $3.38; DNA has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DNA vs PRME: the quick read
- ·PRME is the larger company by market cap ($646M vs $502M).
- ·PRME has been more active on our scanner (284 vs 224 alerts in 30 days).
- ·DNA has the smaller float (65.6M vs 134.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 284 and 224 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 29% of each other on market cap, which makes the rest of this table the interesting part.
- ·PRME pays a dividend and DNA does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching DNA or PRME? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and PRME on TheDesperateTrader.
- Is DNA or PRME the better stock?
- "Better" depends on your goal, and these two are not alike. PRME is the larger company by market cap ($646M vs $502M). PRME has been more active on our scanner (284 vs 224 alerts in 30 days). DNA has the smaller float (65.6M vs 134.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and PRME?
- The differences that matter: they are not in the same business - DNA is biological products, (no diagnostic substances) and PRME is biological products, (no diagnostic substances); they are similar in size ($502M vs $646M); they trade at very different share prices ($7.55 vs $3.56); DNA sits at 17% of its 52-week range against 27% for PRME; only PRME pays a dividend; our scanner flagged DNA 224 times in the last 30 days against 284 for PRME. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and PRME is more active right now?
- Right now DNA is at about 0.8x its normal volume and PRME is at about 1.0x, so PRME is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DNA or PRME in the stronger trend?
- DNA is below its 50-day average of $10.42 and below its 200-day average of $8.63; PRME is below its 50-day average of $3.74 and above its 200-day average of $3.51. PRME leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or PRME? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and PRME comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.